Genes involved in the complement cascade such as complement factor B (CFB) and complement component C2 have been implicated in age-related macular degeneration (AMD) worldwide. In continuation of the analysis of CFH and LOC387715/HTRA1, this study was conducted to gain understanding of the role of CFB and C2 in an Indian AMD cohort.
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PURPOSE. Genes involved in the complement cascade such as complement factor B (CFB) and complement component C2 have been implicated in age-related macular degeneration (AMD) worldwide. In continuation of the analysis of CFH and LOC387715/HTRA1, this study was conducted to gain understanding of the role of CFB and C2 in an Indian AMD cohort.
METHODS. Single nucleotide polymorphisms in CFB and C2
were screened in a cohort of clinically well-characterized patients with AMD (n ϭ 177) and unaffected normal control subjects (n ϭ 175). Screening was accomplished by a combination of customized genotyping followed by validation through resequencing. In addition, genotyping of two CFB variants (rs12614 and rs641153) that were in close proximity had to be resolved by resequencing. Estimates of allele and genotype frequencies, odds ratios, Hardy-Weinberg equilibrium, linkage disequilibrium (LD), and haplotype frequencies were also performed.
RESULTS. Three SNPs in C2 (rs547154 [IVS10]
; P ϭ 5.4 ϫ 10 Ϫ11 ) and CFB (rs641153 [R32Q], P ϭ 2.2 ϫ 10 Ϫ7 and rs2072633 [IVS17]; P ϭ 2.0 ϫ 10 Ϫ4 ) were strongly associated with reduced risk of AMD. The rs547154 and rs641153 were in strong LD (DЈ ϭ 0.90, 95% CI ϭ 0.81-0.96) and a protective haplotype T-A was observed (OR ϭ 0.10, 95% CI ϭ 0.05-0.20). LD was moderate (DЈ ϭ 0.77, 95% CI ϭ 0.67-0.85) between the rs547154 and the rs2072633 SNPs, and the haplotype T-T generated with these SNPs was relatively less protective (OR ϭ 0.28, 95% CI ϭ 0.18 -0.44).
CONCLUSIONS.
The results of the present study provide an independent validation of the association of rs547154 (C2) and rs641153 (CFB) SNPs AMD has a relatively higher prevalence in the developed countries 3, 4 and has gradually become a major health concern in the developing countries including India due to rapidly changing demographics, life styles, and senescence. 5, 6 It is a complex disorder with multifactorial etiology, and genetic susceptibility is a major risk factor. 7, 8 Several chromosomal loci have been mapped in AMD, and two major loci on chromosomes 1q32 and 10q26 harboring the complement factor H (CFH, OMIM ϩ1343370) and a hypothetical gene LOC387715 (OMIM ϩ611313), now known as ARMS2 and a flanking gene HTRA1 (OMIM 602194) have been characterized. 9 -18 Globally, several studies have replicated the association of variants within these genes in AMD across multiple populations. 8, 18 After the discovery of CFH, a series of other genes involved in AMD pathogenesis were discovered in the complement cascade. 8 These included two paralogous genes: complement factor B (CFB; OMIM 138470) and complement component 2 (C2; OMIM ϩ217000) located in the major histocompatibility complex (MHC) class III region on 6p21. 19 The single nucleotide polymorphisms (SNPs) in C2 (rs9332739 [E318D] and rs547154 [IVS10]) and CFB (rs4151667 [L9H] and rs641153 [R32Q]) were observed to be strongly associated with reduced risk of AMD. 19 A strong linkage disequilibrium (LD) was observed between the rs547154 and rs641153 SNPs in two studies of Caucasian populations from the United States 20 and Australia 21 that convincingly replicated these associations in their AMD cohorts. Selective screening of a few C2 and CFB SNPs in two large Caucasian populations that included both familial and case-control cohorts, indicated that rs547154 (C2), 22 and rs9332739 (C2), 23 and rs4151667 (CFB) 23 SNPs, respectively, conferred protection against AMD. A British study of a cohort with neovascular AMD screened with tag-SNPs derived from the HapMap Project harboring the C2/CFB region reported significant associations with the previously associated SNPs in this region. 24 The authors also hypothesized a functional involvement of a potential candidate gene SKIVL2 in AMD that overlay within the LD block of C2/CFB. 24 Thus, it is evident that the CFB and C2 SNPs have been characterized quite extensively in Caucasian populations worldwide, but not in other ethnic groups. Our earlier studies in an Indian AMD cohort had demonstrated the association of CFH and LOC387715/HTRA1 with a risk profile similar to that in Caucasian populations. 25, 26 We now sought to understand the involvement of C2 and CFB in the same cohort and to independently validate the association of these SNPs in AMD.
METHODS

Clinical Characterization of the Cases and Controls
The study conformed to the tenets of the Declaration of Helsinki, and prior approval was obtained from the Institutional Review Board of the L.V. Prasad Eye Institute. A cohort of 512 consecutive subjects included patients with AMD (n ϭ 262) and ethnically matched normal controls (n ϭ 250) drawn from the same geographic region of habitat. Clinical characterization of these cases and controls along with the details of clinical examinations have already been described in our earlier publications in this journal. 25, 26 AMD in each subject was independently diagnosed by two retina specialists with previously laid out inclusion and exclusion criteria. Written informed consent was obtained from all the subjects before their enrollment in the study.
Selection of Variants (SNPs) in the Candidate Genes
We chose multiple arrays of SNPs in each gene for genotyping. The selection criteria were based on previous evidence of association of these SNPs with AMD. We then chose additional flanking SNPs to the associated SNPs, to enlarge the genomic region being screened. Based on these criteria, we chose a set of 12 SNPs that included the CFB (n ϭ 10) and C2 (n ϭ 2) genes ( Table 1) .
Genotyping of SNPs
Customized genotyping was undertaken to initially screen these 12 SNPs (GoldenGate Technology; Illumina, Inc., San Diego, CA) according to the manufacturer's protocol. Genotypes were extracted (Bead Studio software, ver. 3.0; Illumina) through a clustering algorithm. Five independent samples were provided as replicates in each 96-well plate for the sake of validation of the genotypes. Further details are available on request. Among the SNPs in the CFB gene, we could accommodate only one of the SNPs harboring codon 32 (i.e., rs12614 [R32W]) in the assay (GoldenGate Assay; Illumina). Hence the other SNP rs641153 (R32Q) at this codon was screened by resequencing with appropriate primers by using dye termination chemistry on an automated DNA sequencer (Big Dye Termination on a 3130xl sequencer; ABI, Foster City, CA) according to the manufacturer's guidelines.
Validation of SNPs
Apart from replication of the samples in the same and different plates in the assay, resequencing was performed to validate these SNPs in a subset of samples (BigDye Chemistry; ABI) on an automated DNA sequencer (3130xl; ABI). To validate the three associated SNPs, further resequencing was done in the remaining cohort as well as in the previously assayed subjects. There was total concordance between the genotype calls obtained (Bead Analysis software; Illumina) and the SNP sequencing data.
Statistical Analysis
Allele and genotype frequencies were estimated by the gene-counting method and their significance was calculated by 2 statistics. Odds ratios (ORs) were computed to assess the odds of the associated alleles and genotypes. Hardy-Weinberg equilibrium was calculated and haplotype frequencies were estimated with Haploview software (ver. 4.0) which uses the EM algorithm. 27 Permutation tests were performed to assess the extent of association of individual SNPs and haplotype blocks. LD analysis between the SNPs was analyzed using the LD plot function of the software.
RESULTS
Initially, all the 12 SNPs in CFB and C2 were screened in a cohort of 352 subjects (177 AMD cases and 175 controls) by a genotyping assay (GoldenGate Assay; Illumina). Later, we genotyped only the associated SNPs (n ϭ 3) in the remaining cohort (n ϭ 160). Since these additional genotypings did not alter the previous results, we have provided only the data of the original cohort for uniformity with the other SNPs. The rs4151659 (K565E) in CFB was completely monomorphic in the normal controls and was not included for any further analysis. There was no deviation from Hardy-Weinberg equilibrium among the other SNPs in the normal controls.
Analysis of Variants in the C2 and CFB Genes
Screening of C2 and CFB SNPs revealed one SNP in C2 (rs547154 [IVS10]) and two SNPs in CFB (rs641153 [R32Q] and rs2072633 [IVS17]) that were strongly associated with AMD ( Table 1 ). The normal controls exhibited very high frequencies for the minor alleles of rs547154 (P ϭ 5.4 ϫ 10 Ϫ11 ), rs641153 (P ϭ 2.2 ϫ 10 Ϫ7 ) and an intron 17 variant rs2072633 (P ϭ 2.0 ϫ 10 Ϫ4 ). All the P values obtained were significant after Bonferroni corrections for multiple comparisons. The other SNPs in CFB did not exhibit any association to AMD in this cohort. The protective alleles of rs547154 and the rs641153 were strongly associated with reduced risk of AMD, as is evident from their ORs ( Table 1) .
The distribution of genotypes for the three associated SNPs at the C2 and CFB locus in cases and controls are provided in Table 2 . Apparently, the presence of the protective allele(s) in the genotype was significantly associated with the controls.
LD and Haplotype Analysis
The extent of LD was assessed between the three associated SNPs in C2 and CFB. A high LD (DЈ ϭ 0.90, 95% CI ϭ 0.81-0.96) was observed between the rs547154 (C2) and rs641153 (CFB) SNPs (Fig. 1) . LD was also stronger (DЈ ϭ 0.93, 95% CI ϭ 0.83-0.98) between the two CFB SNPs rs641153 and rs2072633 but was moderate (DЈ ϭ 0.77, 95% CI ϭ 0.67-0.85) between the rs547154 (C2) and the rs2072633 (CFB) SNPs.
The distribution of estimated haplotype frequencies based on eight SNPs in C2 and CFB are provided in Table 3 . The other SNPs were not considered as they had an minor allele frequency (MAF) Ͻ3% in the normal population. Only haplotypes with a frequency Ͼ5% in the cohort were considered. Haplotypes generated with the three associated SNPs (rs547154, rs641153, and rs2072633) revealed a protective haplotype, T-A-T, that was strongly associated with a reduced risk of AMD (P ϭ 4.9 ϫ 10 Ϫ14 ). This association was consistent (P ϭ 2.5 ϫ 10 Ϫ14 ), even when the haplotype (T-A) was generated with rs547154 and rs641153 SNPs (Table 3) , similar to previous studies. 19, 21 Based on permutation tests for individual SNPs and haplotype blocks (n ϭ 10,000 permutations), we observed that the rs547154 (C2) and rs641153 (CFB) were the most strongly associated SNPs (permutation 2 ϭ 43.028 and 26.818, respectively, P Ͻ 10 Ϫ8 ), and so was the T-A haplotype (permutation 2 ϭ 58.043, P Ͻ 10 Ϫ6 ). The rs2072633 SNP had a relatively lesser permutation value ( 2 ϭ 13.461, P ϭ 0.003) that was evident when the rs641153 was replaced by rs2072633 to generate a haplotype with rs547154 (T-T) and the association was relatively weaker (permutation 2 ϭ 21.547, P Ͻ 10 Ϫ4 ).
DISCUSSION
The association of variants in CFB and C2 with AMD has been established in multiple Caucasians populations worldwide. 19 -24 To the best of our knowledge, this is the first study that unequivocally validates the association of these SNPs in an AMD cohort from India. Genetic associations are more mean- The bold rows indicate haplotypes based on the combinations of the minor alleles of three strongly associated SNPs in C2 (rs547154) and CFB (rs641153 and rs2072633). ingful when they are replicated across multiple ethnic groups from different geographic regions. 28, 29 These associations help in fine mapping disease associations and in determining whether effect sizes of the associated alleles are similar or different across populations. Nonreplications in association studies could be attributed to genetic heterogeneity or poor design, but a well-designed case-control study with adequate power provides an opportunity to understand the involvement of alleles with modest disease susceptibility. 30, 31 In addition, it provides evidence of the underlying biological mechanism in the disease pathway. 32 Our allelic and haplotype data further confirms the universality of this association in a non-Caucasian population sampled from the Eastern world and provides further support to the implication of the CFB and C2 SNPs in AMD pathogenesis.
The frequency of the protective alleles of rs547154 (C2), rs641153 and rs2072633 (CFB) were higher in the present cohort than in the Caucasian populations ( Table 4) . As is evident from the table, the extent of the association based on these SNPs in the Indian cohort was similar to that observed in the Caucasian populations. The extent of LD between these two SNPs (Fig. 1) was also similar to that observed in AMD cohorts from the United States 20 and Australia. 21 On the other hand, we observed a lower frequency of the protective alleles of rs2072633 SNP in our cohort and a relatively stronger association (P ϭ 2.01 ϫ 10 Ϫ4 ) compared with other populations (Table 4) . This is also reflected in the strong LD (DЈ ϭ 0.93) between these SNPs (Fig. 1) in our cohort. A moderate association was noted for this SNP in the U.S. (P ϭ 0.044) 19 and U.K. cohorts (P ϭ 0.05).
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Haplotype analysis with the associated SNPs in rs547154 (C2) and rs641153 (CFB) indicated a protective haplotype T-A that was significantly associated in the Indian cohort (P ϭ 2.6 ϫ 10 Ϫ14 ), similar to that in the Caucasians. 19, 21 The T-A haplotype exhibited a higher frequency in the normal control (21%) than in other populations. 19, 21 The extent of protection conferred by the T-A haplotype (rs547154 and rs641153) was relatively stronger (OR ϭ 0.10, 95% CI ϭ 0.05-0.20) than the T-T haplotype based on rs547154 and rs2072633 SNPs (OR ϭ 0.28, 95% CI ϭ 0.18 -0.44).
The rs9332739 (E318D; C2) and the rs4151667 (L9H; CFB) SNPs did not exhibit any association (Table 1) , despite a strong LD between these SNPs in the present cohort (Fig. 1) . This finding is in contrast to those in some populations 19, 23, 24 in which strong association of these SNPs was observed, but our data are in agreement with results in a U.S. 20 and an Australian cohort. 21 Nonreplication of genetic association could be attributed to population diversity, rare alleles, effect size of the allele, or a host of other factors. 28, 29 However, these associations tend to be more meaningful when they are supported with functional data relating to the disease.
Recent evidences by Montes et al. 33 have suggested a functional basis of protection for the rs641153 (R32Q) SNP in AMD. The association of AMD with CFB abnormalities strongly suggests that the problem is unregulated activation of the alternative pathway, in which CFB is a critical factor. The authors have convincingly demonstrated the underlying mechanistic details of the rs641153 SNP in regulating the activity of the alternate complement pathway that may lead to a reduced risk of AMD. 33 But, since the association of the CFB (rs641153) is directly linked to C2 (rs547154), it would also be interesting to know the combined functional effect of both these SNPs involving the classic pathway.
In summary, we have provided an independent replication of the association of C2 and CFB in an Indian AMD cohort. These results mimic our previous associations with respect to CFH and LOC387715 variants, wherein, our data resembled a similar genetic profile as observed in Caucasian populations. 25, 26 Haplotype analysis further refined the region of association harboring the rs547154 and rs641153 SNPs in C2 and CFB. Although our sample sizes were relatively smaller than those from Caucasian populations, these associations underscore the role of C2 and CFB SNPs in AMD pathogenesis and could be used for risk assessment in the Indian cohort. 
